#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Tuberous sclerosis complex Postprandial hypoglycaemia Type IIa hyperlipidaemia Lennox-Gastaut syndrome Red blood cell abnormality Glioblastoma Adrenocortical carcinoma Phaeochromocytoma Acquired C1 inhibitor deficiency Mitochondrial encephalomyopathy Congenital megacolon Chronic lymphocytic leukaemia refractory CDKL5 deficiency disorder Ewing's sarcoma recurrent Transitional cell cancer of the renal pelvis and ureter More trials…

    Learn about Rare Diseases

    KBG syndrome – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information Hereditary ataxia – Basic Information Waldenstrom’s macroglobulinaemia refractory – Treatment Inclusion body myositis Andersen-Tawil syndrome – Trials in Disease Medulloblastoma recurrent – Life with Disease Activated PI3 kinase delta syndrome – Treatment Nephroblastoma – Diagnostics Mantle cell lymphoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ZINC CHLORIDE Cpft Trifluoroacetate Elvn-002-1 Aflibercept Abc-23B-116 BI-1607 Abiraterone Acetate Arginine Hydrochloride Vilanterol Allogeneic Faecal Microbiota BNT327 DESMOPRESSIN ACETATE Tipiracil Lithium Carbonate Romosozumab Db-Oto-5 Sodium Hyaluronate HRS 9531 Doxorubicin Metformin Embonate More therapies…

    Learn about Your Condition

    Food allergy Aplastic anaemia Endometrial cancer Combined immunodeficiency Ovarian epithelial cancer Spinal muscular atrophy Psoriasis Osteonecrosis of jaw Fallopian tube cancer stage IV Pseudomyxoma peritonei Pain Escherichia infection Colorectal cancer stage II Hypoglycaemia Laryngeal cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of sufentanil versus midazolam for pain relief during egg retrieval in women undergoing fertility treatment

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Sufentanil
    • Diclofenac Sodium
    • Alprazolam
    Belgium

  • A Study of Watchful Waiting After Chemotherapy and Radiotherapy Compared to Surgery for Patients with Early Rectal Cancer Using Capecitabine

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Capecitabine
    Sweden

  • Study of abemaciclib and its connection to severe diarrhea in patients with hormone receptor-positive breast cancer at high risk of return

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Abemaciclib
    France

  • A Study of Blinatumomab in Children with Relapsed or Treatment-Resistant B Cell Acute Lymphoblastic Leukemia with Remaining Disease Traces

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia recurrent
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Blinatumomab
    France Italy The Netherlands

  • Testing the effectiveness and safety of remimazolam, ketamine, and propofol for rapid sequence induction in patients at risk of aspiration

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Ketamine
    • Remimazolam
    • Propofol
    France

  • Study of drug combination with radiotherapy versus radiotherapy alone for locally advanced rectal cancer in patients 75 years and older

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal adenocarcinoma
    Investigated Drugs:
    • Calcium Levofolinate
    • Fluorouracil
    • Folinic Acid
    France
Previous Page
1 … 754 755 756 757 758 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!